Research Use Only. KIRhub outputs are computational research artifacts. They are not validated for clinical decision-making, diagnosis, or treatment.
KIRhub 2.0
Sign in

SRR29022828

· B

f2b68b19-d12f-5bb0-b6f9-a3194f995c6a

Score in workbench →

Clinical attributes

From the source cohort, normalized into canonical keys plus the project's native columns.

cancer_type
cancer_type_detailed
subtype
B
subtype
B

GSVA pathway preview (50 Hallmark scores)

MeasuredDerivedReference

Top 10 most elevated and top 10 most suppressed Hallmark pathways for this sample.

Top 10 elevated

  • ESTROGEN_RESPONSE_EARLY+0.340
  • ESTROGEN_RESPONSE_LATE+0.180
  • PEROXISOME+0.160
  • DNA_REPAIR+0.070
  • SPERMATOGENESIS+0.060
  • BILE_ACID_METABOLISM+0.050
  • PROTEIN_SECRETION+0.040
  • UNFOLDED_PROTEIN_RESPONSE+0.010
  • HEME_METABOLISM+0.000
  • MYC_TARGETS_V2-0.060

Top 10 suppressed

  • ALLOGRAFT_REJECTION-0.630
  • INTERFERON_GAMMA_RESPONSE-0.620
  • TNFA_SIGNALING_VIA_NFKB-0.590
  • INTERFERON_ALPHA_RESPONSE-0.580
  • EPITHELIAL_MESENCHYMAL_TRANSITION-0.570
  • IL6_JAK_STAT3_SIGNALING-0.550
  • INFLAMMATORY_RESPONSE-0.550
  • ANGIOGENESIS-0.440
  • COMPLEMENT-0.430
  • KRAS_SIGNALING_UP-0.430

Patient twins — nearest pathway neighbors

MeasuredDerived

10 samples closest to this one in 50-dim pathway space, drawn from the Pathway Atlas. Cosine similarity = 1 means identical pathway state.

7 twins match this tumor's tissue · 3 come from a different tissue of origin

#SampleCancer typeSubtypecos similarity
1TCGA-E2-A15G-01A-11R-A12D-07
breast-umap@18
B0.915
2MBCProject_0343_T1_RNA
breast-umap@18
B0.902
3SRR25617889
breast-umap@18
B0.901
4SRR35579848
breast-umap@18
B0.900
5TCGA-A7-A0DC-01A-11R-A00Z-07
breast-umap@18
D0.890
6SRR1398992
brain-umap@2
GTEX0.889
7SRR1322163
brain-umap@2
GTEX0.888
8a50c02ec-6ba9-4678-990d-6c74a8e9b7b5
colon-landscapes@1
0.884
9TCGA-G2-AA3F-01A-12R-A42T-07
bladder-landscape@3
0.883
10SRR1385036
brain-umap@2
GTEX0.881

Per-pathway drug coverage

ModeledCalibratedDerived

For each elevated pathway in this tumor, the best-reversing drug across the catalog. Uncovered pathways = unmet need at pathway level for this one patient.

0 of 8 elevated pathways have at least one drug that meaningfully reverses them.

Pathway (elevated)tumor scoreBest drugreversal magnitude
ESTROGEN_RESPONSE_EARLY0.340Inavolisib— uncovered
ESTROGEN_RESPONSE_LATE0.180Idelalisib— uncovered
PEROXISOME0.160Idelalisib— uncovered
DNA_REPAIR0.070Idelalisib— uncovered
SPERMATOGENESIS0.060Inavolisib— uncovered
BILE_ACID_METABOLISM0.050Inavolisib— uncovered
PROTEIN_SECRETION0.040Remibrutinib— uncovered
UNFOLDED_PROTEIN_RESPONSE0.010Idelalisib— uncovered